Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
Riad Salem(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Margaret Gilbertsen(Northwestern University), Ryan Hickey(New York University), Al B. Benson(Northwestern University), Khairuddin Memon(Northwestern University), Mary F. Mulcahy(Northwestern University), David Cella(Northwestern University), Zeeshan Butt(Northwestern University), Michaël Abécassis(University of Arizona), Ahsun Riaz(Northwestern University), Laura Kulik(Northwestern University), James Burns(Northwestern University), Michaël Vouche(Université Libre de Bruxelles), Daniel Ganger(Northwestern University), Talia Baker(University of Utah)
Cited by 258
Related Papers
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k